David Larsen
Stock Analyst at BTIG
(2.11)
# 2,910
Out of 4,920 analysts
76
Total ratings
35%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $12.91 | +93.65% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $6.74 | +48.37% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $57.93 | +38.10% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $23.22 | +20.59% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $55.52 | -36.96% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $91.01 | +42.84% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $20.02 | +54.85% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $183.93 | +41.36% | 2 | Nov 1, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $19.85 | +0.76% | 2 | Oct 3, 2024 | |
| ASTH Astrana Health | Maintains: Buy | $60 → $70 | $22.32 | +213.62% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.88 | +80.41% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $281.46 | -14.73% | 1 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.40 | +400.00% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $11.84 | +18.24% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.00 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.50 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $9.50 | +373.68% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.82 | +450.46% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.88 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.45 | +79.95% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.96 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $8.48 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $158.24 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $709.49 | -77.45% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $11.69 | +498.80% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $64.83 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $63.42 | +34.03% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $6.51 | +253.30% | 1 | Nov 2, 2017 |
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $12.91
Upside: +93.65%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $6.74
Upside: +48.37%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $57.93
Upside: +38.10%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $23.22
Upside: +20.59%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $55.52
Upside: -36.96%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $91.01
Upside: +42.84%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $20.02
Upside: +54.85%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $183.93
Upside: +41.36%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $19.85
Upside: +0.76%
Astrana Health
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $22.32
Upside: +213.62%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.88
Upside: +80.41%
Jul 9, 2024
Initiates: Buy
Price Target: $240
Current: $281.46
Upside: -14.73%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.40
Upside: +400.00%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $11.84
Upside: +18.24%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $30.50
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $9.50
Upside: +373.68%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.82
Upside: +450.46%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $0.88
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $19.45
Upside: +79.95%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.96
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $8.48
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $158.24
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $709.49
Upside: -77.45%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $11.69
Upside: +498.80%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $64.83
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $63.42
Upside: +34.03%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $6.51
Upside: +253.30%